Your browser doesn't support javascript.
loading
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
Park, Sehhoon; Kim, Tae Min; Han, Ji-Youn; Lee, Gyeong-Won; Shim, Byoung Yong; Lee, Yun-Gyoo; Kim, Sang-We; Kim, Il Hwan; Lee, Suee; Kim, Yu Jung; Park, Ji Hyun; Park, Sang-Gon; Lee, Ki Hyeong; Kang, Eun Joo; Kim, Ju Won; Shin, Seong-Hoon; Ock, Chan-Young; Nam, Byung-Ho; Lee, Jaebong; Jung, Hyun-Ae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju.
Affiliation
  • Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul, Korea.
  • Han JY; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang-si Gyeonggi-do, Korea.
  • Lee GW; Divisions of Hematology and Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
  • Shim BY; Division of Medical Oncology, Department of Internal Medicine, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee YG; Division of Hematology & Medical Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim SW; Division of Oncology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim IH; Department of Internal Medicine, Division of Hemato-Oncology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Lee S; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Kim YJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Park JH; Department of Hemato-oncololgy, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Park SG; Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Korea.
  • Lee KH; Division of Hematology-Oncology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
  • Kang EJ; Division of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Kim JW; Divisions of Hematology-Oncology, Department of Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • Shin SH; Division of Hemato-Oncology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.
  • Ock CY; Lunit, Seoul, Korea.
  • Nam BH; Herings, Seoul, Korea.
  • Lee J; Seoul CRO, Seoul, Korea.
  • Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Clin Oncol ; 42(11): 1241-1251, 2024 Apr 10.
Article in En | MEDLINE | ID: mdl-37861993
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / Lung Neoplasms Limits: Humans Language: En Journal: J Clin Oncol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / Lung Neoplasms Limits: Humans Language: En Journal: J Clin Oncol Year: 2024 Document type: Article